Merck & Co., Inc. (MRK)
Last updated: 2026-10-23 05:24:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Merck & Co., Inc. (MRK) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $147.21, with a market capitalization of $369.78B and a P/E ratio of 116.54. Over the past 52 weeks, its price has ranged from $82.01 to $156.92. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$369.78B | |
$151.05 | |
$156.92 | |
$15.32 | |
$149.88 | |
16.93M | |
10.15M | |
116.54 | |
$156.92 | |
$82.01 | |
2.24% | |
-- |
Merck & Co., Inc. (MRK) Latest Closing Stock Price
Merck & Co., Inc. (MRK) last closed at $149.88 as of 2026-10-23 00:01:00, unchanged from the previous close of $149.88.
During the latest regular trading session, MRK traded between $15.32 and $156.92, with a volume of 16.93M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Merck & Co., Inc. (MRK) 7-Day Stock Price Change
Over the past seven days, Merck & Co., Inc. (MRK) moved from $147.37 to $147.21, representing a decline of 0.11% ($0.16).
The stock traded between $142.66 and $154.02 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 11.90 million shares, up versus the previous seven-day period, indicating higher trading activity.
MRK 52-Week Price Position
Position in Range: 87.0%
MRK is currently trading at $147.21, placing it 87.0% of the way from its 52-week low of $82.01 to its 52-week high of $156.92. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Merck & Co., Inc. (MRK)?
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).
Merck & Co., Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 75000 |
| Exchange | NYSE |
| Company Website |
How to Buy Merck & Co., Inc. (MRK) Stock on MEXC
Eligible investors can buy real shares of Merck & Co., Inc. (MRK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Merck & Co., Inc. (MRK) stock price today?
2.Is MRK stock going up or down today?
3.What is MRK pre-market price?
4.What is MRK after-hours price?
5.Is MRK stock trading now?
6.Where does MRK sit relative to its 52-week high and low?
7.What sector is Merck & Co., Inc. in?
8.What is Merck & Co., Inc.'s market capitalization and where is it listed?
9.How is MRK valued in terms of P/E ratio and EPS?
10.Does Merck & Co., Inc. pay a dividend?
Explore More US Stocks
Search Stocks
MRK Stock Calculator
Estimate the value between MRK shares and USD.
MRK Shares to USD
1.00 MRK shares = 147.207 USD
Calculations are estimates based on the latest available price and are for reference only.



